MedXCell SA
THE EUROPEAN CELL THERAPY VENTURE BUILDER
MedXCell is a private Swiss cell therapy venture builder. MedXCell aims to reduce that gap and improve the
transformation of cell therapy scientific discoveries into commercial assets to improve human life. Leveraging excellent European science, MedXCell intends to create, fund and operationally manage new start-up companies from academic research.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
31.12.2021
Engage discussion with Regulatory Authorities
31.08.2021
Refine the composition of the Directors of the Board
31.12.2012
Raise Series B funding round
No Jobs
No videos and documents
No Awards
MedXCell SA
THE EUROPEAN CELL THERAPY VENTURE BUILDER
Website:
medxcell.ch/
Headquarter:
1820 Montreux
Foundation Date:
February 2016
Technology:
- Biotech
Sectors:
- Antibodies
- Biotech
- Drug development platforms